flow trial semaglutide results versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials Two-year effects of semaglutide in

Notably, the SURMOUNT-2 trial showed body weight loss of 9.6% and 11.6% more than placebo and A1C lowering of 1.55% and 1.57% more than placebo after 72 weeks of treatment with the 10 mg and 15 mg doses, respectively

For women who have plateaued on tirzepatide at 10 or 15mg, the transition to retatrutide is one of the most clinically rational next steps available

And if you've got side effects that are a rate of one in a million, then randomised trials will not necessarily pick those up, particularly if what they've done, which is what they did do in some of these trials, of these GLP-1 agonists, is that they didn't allow people who had mental health issues or who are on antidepressants onto the trials

Effect of sodium-glucose cotransporter 2 inhibitors on weight reduction in overweight and obese populations without diabetes: a systematic review and a meta-analysis

Most people with the condition need to take insulin multiple times every day, often deciding themselves how much insulin to take and when

Tums may also reduce other semaglutide side effects like heartburn and indigestion